This article explores the need for a holistic risk management framework to address the evolving AI use cases in healthcare. As part of our 2025 Integrated Risk Roadmap, we emphasize the critical role of IRM in ensuring that AI-driven innovations align with ethical standards, regulatory expectations, and patient trust.

Today, January 17, 2025, marks a turning point for the European financial sector as the Digital Operational Resilience Act (DORA) officially takes effect. This comprehensive EU regulation introduces a harmonized framework for managing ICT risks, requiring financial institutions and their ICT third-party service providers (TPSPs) to meet stringent requirements for governance, incident reporting, and resilience. This article explores the implications of DORA, highlights the four key objectives of IRM, and provides guidance for financial institutions as they navigate this new regulatory environment. For further insights, visit wheelhouseadvisors.com.

In financial services, generative AI (GenAI) has rapidly emerged as both a transformative opportunity and a formidable risk. According to a recent ORX survey, three-quarters of financial institutions now classify oversight of GenAI under operational risk. This pivotal shift highlights how GenAI is increasingly perceived as a broader business risk rather than merely a technology-specific challenge. For banks and other financial institutions, this development underscores the necessity of integrated risk management (IRM) frameworks to effectively navigate the complexities of AI adoption.

In the intricate world of risk management, where every decision plays a crucial part in the overall performance of a business, envisioning the integrated approach of governance, risk, and compliance (GRC) alongside Technology Risk Management (TRM), Operational Risk Management (ORM), and Enterprise Risk Management (ERM) as a symphony orchestra offers a compelling narrative.